Effects of standard glucocorticoid replacement therapies on subjective well-being: A randomized, double-blind, crossover study in patients with secondary adrenal insufficiency

European Journal of Endocrinology

Volumn 167, Issue 5, 2012, Pages 679-685

  Benson, Sven ^a   Neumann, Pia ^a   Unger, Nicole ^a   Schedlowski, Manfred ^a   Mann, Klaus ^a   Elsenbruch, Sigrid ^a   Petersenn, Stephan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PLACEBO; PREDNISONE;

ADRENAL INSUFFICIENCY; ADULT; AGE DISTRIBUTION; ARTICLE; BRIEF SYMPTOM INVENTORY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDUCATIONAL STATUS; EMOTIONAL STRESS; EMPLOYMENT STATUS; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SHORT FORM 36; WELLBEING;

ADRENAL INSUFFICIENCY; ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERMANY; GLUCOCORTICOIDS; HEALTH STATUS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPHYSECTOMY; LANGUAGE; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TRANSLATIONS;

EID: 84867561400     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0351     Document Type: Article

References (20)

1. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 1059-1067. (doi:10.1210/jc.2009-0032)
2. Lovas K, Loge JH & Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology 2002 56 581-588. (doi:10.1046/j.1365-2265.2002.01466.x)
3. Thomsen AF, Kvist TK, Andersen PK & Kessing LV. The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology 2006 31 614-622. (doi:10.1016/j.psyneuen.2006.01.003)
4. Arlt W, Rosenthal C, Hahner S & Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurement. Clinical Endocrinology 2006 64 384-389. (doi:10.1111/j.1365-2265.2006.02473.x)
5. Groves RW, Toms GC, Houghton BJ & Monson JP. Corticosteroid replacement therapy: twice or thrice daily? Journal of the Royal Society of Medicine 1988 81 514-516.
6. Wichers M, Springer W, Bidlingmaier F & Klingmuller D. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism. Clinical Endocrinology 1996 50 759-765. (doi:10.1046/j.1365-2265.1999.00723.x)
7. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W & Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 3912-3922. (doi:10.1210/jc.2007-0685)
8. Bleicken B, Hahner S, Loeffler M, Ventz M, Allolio B & Quinkler M. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. European Journal of Endocrinology 2008 159 811-817. (doi:10.1530/EJE-08-0578)
9. Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B &Quinkler M. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clinical Endocrinology 2010 72 297-304. (doi:10.1111/j.1365-2265.2009.03596.x)
10. Riedel M, Wiese A, Schurmeyer TH & Brabant G. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Experimental and Clinical Endocrinology 1993 101 106-111. (doi:10.1055/s-0029-1211215)
11. Alonso N, Granada ML, Lucas A, Salinas I, Reverter J, Oriol A &Sanmarti A. Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters. Journal of Endocrinological Investigation 2004 27 449-454. (Pubitemid 38961257)
12. Hautzinger M, Bailer M, Worall H & Keller F. Beck-Depressions- Inventar (BDI). Bern: Hans Huber, 1995.
13. Bullinger M & Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe Verlag, 1998.
14. Derogatis LR, Rickels K & Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. British Journal of Psychiatry 1976 128 280-289. (doi:10.1192/bjp.128.3.280)
15. Zerssen D. Die Befindlichkeits-Skala - Bf-S. Weinheim: Beltz, 1976.
16. Glenville M & Broughton R. Reliability of the Stanford Sleepiness Scale compared to short duration performance tests and the Wilkinson Auditory Vigilance Task. Advances in Bioscience 1978 21 235-244.
17. Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W &Ross RJ. Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism 2009 94 1548-1554. (doi:10.1210/jc.2008-2380)
18. Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T & Skrtic S. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. European Journal of Endocrinology 2009 161 119-123. (doi:10.1530/EJE-09-0170)
19. Baker SJK & Wass JAH. Addison's disease. BMJ 2009 339 b2384. (doi:10.1136/bmj.b2384)
20. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA &Biermasz NR. Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2011 96 964-971. (doi:10.1210/jc.2010-2490)